Pharmacologic profiling of patient-derived xenograft models of primary treatment-naïve triple-negative breast cancer
Reid T. Powell(Texas A&M Health Science Center), Helen Piwnica‐Worms(Centre for Cancer Biology), Christopher P. Vellano(The University of Texas MD Anderson Cancer Center), Jason B. White(The University of Texas MD Anderson Cancer Center), Xinhui Zhou(Guangxi Academy of Agricultural Science), Shirong Cai(Sun Yat-sen University), Virginia Giuliani(The University of Texas MD Anderson Cancer Center), Joseph R. Marszalek(The University of Texas MD Anderson Cancer Center), XiaoYan Ma(The University of Texas MD Anderson Cancer Center), Gloria V. Echeverria(Baylor College of Medicine), Timothy P. Heffernan(The University of Texas MD Anderson Cancer Center), Ningping Feng(The University of Texas MD Anderson Cancer Center), Abena B. Redwood(The University of Texas MD Anderson Cancer Center), Clifford Stephan(Texas A&M Health Science Center), Peter J. Davies(Texas A&M Health Science Center), Xiaomei Zhang(The University of Texas MD Anderson Cancer Center), Lei Guo(Hunan Provincial Center for Disease Control and Prevention), Yuan Qi(The University of Texas MD Anderson Cancer Center), Yan Jiang(Southwest University), Xuan Liu(Fudan University), Stacy Moulder(The University of Texas MD Anderson Cancer Center), W. Fraser Symmans(The University of Texas MD Anderson Cancer Center), Yizheng Tu(The University of Texas MD Anderson Cancer Center), Jeffrey T. Chang(Tufts University)
Cited by 22
Related Papers
Palbociclib and Letrozole in Advanced Breast Cancer
|New England Journal of Medicine|2016|2.9k
Measurement of Residual Breast Cancer Burden to Predict Survival After Neoadjuvant Chemotherapy
|Journal of Clinical Oncology|2007|1.6k
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
|Proceedings of the National Academy of Sciences|2009|1.4k
Neoadjuvant Chemotherapy, Endocrine Therapy, and Targeted Therapy for Breast Cancer: ASCO Guideline
|Journal of Clinical Oncology|2021|991